Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 May 1;90(9):3923–3927. doi: 10.1073/pnas.90.9.3923

In vivo expression of mutant preproendothelins: hierarchy of processing events but no strict requirement of Trp-Val at the processing site.

M S Fabbrini 1, A Vitale 1, E Pedrazzini 1, G Nitti 1, M Zamai 1, M Tamburin 1, V R Caiolfa 1, C Patrono 1, L Benatti 1
PMCID: PMC46418  PMID: 8483912

Abstract

Endothelin-1 (ET-1), a 21-residue vasoconstrictor peptide, originates in human cells from a 212-amino acid precursor (preproET-1). Big ET-1, an intermediate form of 38 amino acids, is generated by cleavage at basic-pair residues of proET-1, while a specific "ET-converting enzyme" was proposed to process the unusual Trp-Val site at positions 21 and 22 of big ET-1. We have previously shown that expression of synthetic RNA encoding human preproET-1 in Xenopus oocytes results in secretion of putative ET-1 and big ET-1. Here, to further dissect the processing pathway of preproET-1, we designed and expressed in oocytes a set of preproET-1 mutants. Four mutants affecting the Trp-Val site always originated putative ET-1(s) at levels comparable to the wild type, suggesting that there is only a conformational requirement for cleavage at this site. An Arg-->Ile mutation at the basic-pair site after the C terminus of big ET-1 fully inhibited the formation of both big ET-1 and ET-1, indicating that processing at this site is an early event and that big ET-1 is an obligate intermediate for the synthesis of ET-1 in vivo. Also, a truncated mutant bearing a stop codon after the C terminus of the big ET-1 sequence was totally stable and further processed into mature big ET-1 and ET-1, indicating that the second part of the precursor is not necessary for maturation.

Full text

PDF
3923

Images in this article

3924Fig. 2
on p.3924
3925Fig. 3
on p.3925
3925Fig. 4
on p.3925

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr P. J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell. 1991 Jul 12;66(1):1–3. doi: 10.1016/0092-8674(91)90129-m. [DOI] [PubMed] [Google Scholar]
  2. Benatti L., Cozzi L., Zamai M., Tamburin M., Vaghi F., Caiolfa V. R., Fabbrini M. S., Sarmientos P. Human preproendothelin-1 is converted into active endothelin-1 by baculovirus-infected insect cells. Biochem Biophys Res Commun. 1992 Jul 31;186(2):753–759. doi: 10.1016/0006-291x(92)90810-8. [DOI] [PubMed] [Google Scholar]
  3. Berg D. T., Grinnell B. W. Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1289–1296. doi: 10.1016/0006-291x(91)91713-m. [DOI] [PubMed] [Google Scholar]
  4. Bloch K. D., Friedrich S. P., Lee M. E., Eddy R. L., Shows T. B., Quertermous T. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem. 1989 Jun 25;264(18):10851–10857. [PubMed] [Google Scholar]
  5. Bresnahan P. A., Leduc R., Thomas L., Thorner J., Gibson H. L., Brake A. J., Barr P. J., Thomas G. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol. 1990 Dec;111(6 Pt 2):2851–2859. doi: 10.1083/jcb.111.6.2851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ceriotti A., Pedrazzini E., Fabbrini M. S., Zoppe M., Bollini R., Vitale A. Expression of the wild-type and mutated vacuolar storage protein phaseolin in Xenopus oocytes reveals relationships between assembly and intracellular transport. Eur J Biochem. 1991 Dec 18;202(3):959–968. doi: 10.1111/j.1432-1033.1991.tb16456.x. [DOI] [PubMed] [Google Scholar]
  7. Doherty A. M. Endothelin: a new challenge. J Med Chem. 1992 May 1;35(9):1493–1508. doi: 10.1021/jm00087a001. [DOI] [PubMed] [Google Scholar]
  8. Ensinck J. W., D'Alessio D. A. The enteroinsular axis revisited. A novel role for an incretin. N Engl J Med. 1992 May 14;326(20):1352–1353. doi: 10.1056/NEJM199205143262009. [DOI] [PubMed] [Google Scholar]
  9. Fabbrini M. S., Valsasina B., Nitti G., Benatti L., Vitale A. The signal peptide of human preproendothelin-1. FEBS Lett. 1991 Jul 29;286(1-2):91–94. doi: 10.1016/0014-5793(91)80948-3. [DOI] [PubMed] [Google Scholar]
  10. Fabbrini M. S., Vitale A., Patrono C., Zamai M., Vaghi F., Caiolfa V., Monaco L., Benatti L. Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8939–8943. doi: 10.1073/pnas.88.20.8939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Giaid A., Gibson S. J., Ibrahim B. N., Legon S., Bloom S. R., Yanagisawa M., Masaki T., Varndell I. M., Polak J. M. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7634–7638. doi: 10.1073/pnas.86.19.7634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gutniak M., Orskov C., Holst J. J., Ahrén B., Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 1992 May 14;326(20):1316–1322. doi: 10.1056/NEJM199205143262003. [DOI] [PubMed] [Google Scholar]
  13. Higuchi R., Krummel B., Saiki R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988 Aug 11;16(15):7351–7367. doi: 10.1093/nar/16.15.7351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Itoh Y., Yanagisawa M., Ohkubo S., Kimura C., Kosaka T., Inoue A., Ishida N., Mitsui Y., Onda H., Fujino M. Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett. 1988 Apr 25;231(2):440–444. doi: 10.1016/0014-5793(88)80867-6. [DOI] [PubMed] [Google Scholar]
  15. Kloog Y., Ambar I., Sokolovsky M., Kochva E., Wollberg Z., Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science. 1988 Oct 14;242(4876):268–270. doi: 10.1126/science.2845579. [DOI] [PubMed] [Google Scholar]
  16. Korner J., Chun J., O'Bryan L., Axel R. Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11393–11397. doi: 10.1073/pnas.88.24.11393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Krieg P. A., Melton D. A. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucleic Acids Res. 1984 Sep 25;12(18):7057–7070. doi: 10.1093/nar/12.18.7057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nagahama M., Ikemizu J., Misumi Y., Ikehara Y., Murakami K., Nakayama K. Evidence that differentiates between precursor cleavages at dibasic and Arg-X-Lys/Arg-Arg sites. J Biochem. 1991 Nov;110(5):806–811. doi: 10.1093/oxfordjournals.jbchem.a123664. [DOI] [PubMed] [Google Scholar]
  19. Salvati P., Dho L., Calabresi M., Rosa B., Patrono C. Evidence for a direct vasoconstrictor effect of big endothelin-1 in the rat kidney. Eur J Pharmacol. 1992 Oct 20;221(2-3):267–273. doi: 10.1016/0014-2999(92)90712-d. [DOI] [PubMed] [Google Scholar]
  20. Simonson M. S., Dunn M. J. Endothelins: a family of regulatory peptides. State-of-the-art lecture. Hypertension. 1991 Jun;17(6 Pt 2):856–863. doi: 10.1161/01.hyp.17.6.856. [DOI] [PubMed] [Google Scholar]
  21. Thomas L., Leduc R., Thorne B. A., Smeekens S. P., Steiner D. F., Thomas G. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5297–5301. doi: 10.1073/pnas.88.12.5297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  23. Yoshizawa T., Shinmi O., Giaid A., Yanagisawa M., Gibson S. J., Kimura S., Uchiyama Y., Polak J. M., Masaki T., Kanazawa I. Endothelin: a novel peptide in the posterior pituitary system. Science. 1990 Jan 26;247(4941):462–464. doi: 10.1126/science.2405487. [DOI] [PubMed] [Google Scholar]
  24. Zoja C., Orisio S., Perico N., Benigni A., Morigi M., Benatti L., Rambaldi A., Remuzzi G. Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-beta, thrombin, and a thromboxane A2 analogue. Lab Invest. 1991 Jan;64(1):16–20. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES